Latest Breaking News On - Elizabeth yeu lin - Page 5 : comparemela.com

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) Director Elizabeth Yeu Lin bought 9,506 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were acquired at an average cost of $16.80 per share, for a total transaction of $159,700.80. Following the purchase, the director now directly owns 15,866 […]

United statesWilliam blairElizabeth yeu linTarsus pharmaceuticals price performanceGoldman sachs group incQuarter for tarsus pharmaceuticalsRoyal bankTarsus pharmaceuticalsNews ratings for tarsus pharmaceuticals dailyHedge funds weigh in on tarsus pharmaceuticalsTarsus pharmaceuticals incWells fargo companySecurities exchange commissionGet free reportDirector elizabeth yeu linExchange commission